These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16118939)

  • 21. Treatment of dry eye disease by the non-ophthalmologist.
    Foulks GN
    Rheum Dis Clin North Am; 2008 Nov; 34(4):987-1000, x. PubMed ID: 18984417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
    Russo PA; Bouchard CS; Galasso JM
    Eye Contact Lens; 2007 May; 33(3):144-7. PubMed ID: 17502749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.
    Dastjerdi MH; Hamrah P; Dana R
    Cornea; 2009 Dec; 28(10):1091-6. PubMed ID: 19770713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease.
    Murphy PT; Sivakumaran M; Fahy G; Hutchinson RM
    Bone Marrow Transplant; 1996 Sep; 18(3):641-2. PubMed ID: 8879631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
    Rao SN
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):603-9. PubMed ID: 21999340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation.
    Tarnawska D; Wylegała E
    Eye (Lond); 2007 Dec; 21(12):1493-500. PubMed ID: 17057649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of ocular surface inflammation in Sjögren syndrome.
    Hyon JY; Lee YJ; Yun PY
    Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
    Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
    Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease.
    Yoon KC; Jeong IY; Im SK; Park YG; Kim HJ; Choi J
    Bone Marrow Transplant; 2007 Feb; 39(4):231-5. PubMed ID: 17211430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of budesonide mouthwash on oral chronic graft versus host disease.
    Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
    Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.
    Devecı H; Kobak S
    Int Ophthalmol; 2014 Oct; 34(5):1043-8. PubMed ID: 24442759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
    Spiryda LB; Laufer MR; Soiffer RJ; Antin JA
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):760-5. PubMed ID: 14677115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of dry eye syndrome and Sjogren's syndrome in patients with rheumatoid arthritis.
    Kosrirukvongs P; Ngowyutagon P; Pusuwan P; Koolvisoot A; Nilganuwong S
    J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S61-9. PubMed ID: 22696854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
    Roberts CW; Carniglia PE; Brazzo BG
    Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.